Search results
First Citizens rides growth streak to Fortune 500 - Triangle Business Journal
The Business Journals· 13 hours agoAmong the 14 companies making their debut Tuesday on the 70th annual Fortune 500 list is First...
‘Under Paris’ Review: At Last, a Shark Movie Worthy of Swimming in the Wake of ‘Jaws’
Variety· 13 hours ago“What if there were a shark in the Seine?” is, one can only assume, a question that Parisians ponder...
Should You Buy Nvidia at a New All-Time High?
Motley Fool via Yahoo Finance· 3 days agoData center revenue soared 427% year over year to $22.6 billion, and accounts for 87% of the company's first-quarter revenue. The growing demand for...
Leonard Schleifer
Fortune· 19 hours agoToday its monoclonal antibodies, particularly Eylea for retinal diseases, are producing major cash injections for the company. Indeed, Eylea is on track for mega-blockbuster
Walmart and Chipotle Soared After Announcing Stock Splits. Will Nvidia Be Next?
Motley Fool via Yahoo Finance· 21 hours agoThey're choosing to split their shares because they believe their stock prices will continue to...
TEVA Stock Rises 135% in a Year: What's Driving the Recovery?
Zacks· 1 day agoTeva Pharmaceutical Industries Limited’s (TEVA Quick QuoteTEVA - Free Report) revenues have suffered...
Walmart and Chipotle Soared After Announcing Stock Splits. Will Nvidia Be Next?
The Motley Fool via AOL· 21 hours agoThey're choosing to split their shares because they believe their stock prices will continue to...
Roivant Sciences Ltd (ROIV) Q4 Earnings: EPS Beats Estimates Des
Guru Focus· 6 days agoRevenue: $28.93 million for the quarter, below the analyst estimate of $32.10 million.GAAP EPS: Loss of $0.19 per share for the quarter, compared to a loss of
2 Top Artificial Intelligence (AI) Stocks to Buy Following Nvidia's Blockbuster Earnings
The Motley Fool via AOL· 4 days agoThe initial production ramp-up of Nvidia's new chips seems to be driving solid growth for TSMC...
1 Beaten-Down S&P 500 Dividend Stock to Buy in June and Hold For a Decade or Longer
Motley Fool via Yahoo Finance· 22 hours agoLorbrena and Padcev are poised for sales explosions, and there could be more oncology blockbusters...